1 - 3 of
3 for companies in category
Analysis in
Australia:
AION has focused on development of early stage diagnostics based on its nano-scale platform; modified porous silicon (mpSi).
A nano-biotechnology company with a nanoscale drug discovery technique for systematically scanning 'molecular diversity space'. The company has also developed technology for molecular manufacturing.
Ambri's technology is a novel biosensor technology based upon a synthetic self assembling membrane. The membrane acts like a biological switch and is capable of detecting the presence of specific molecules, and signalling their presence by triggering an electrical current.
[First Page] [Prev] Showing page 1 of 1 pages [Next] [Last Page]
